Lipid abnormalities in HIV-Infected patients and lopinavir plasma concentrations.
Gutiérrez
Félix
F
Padilla
Sergio
S
Navarro
Andrés
A
Masiá
Mar
M
Hernández
Ildefonso
I
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000097:blood*; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000097:blood / Q000209:etiology; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000209:etiology*; D008055:Lipids / Q000097:blood; D061466:Lopinavir; D011446:Prospective Studies; D011744:Pyrimidinones / Q000009:adverse effects* / Q000097:blood*; D019438:Ritonavir / Q000009:adverse effects
D019380:Anti-HIV Agents; D008055:Lipids; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir